APO PHARM ApS: Financial statements 2024
CVR: 15226072
Source: annual report 2024, Danish Business Authority
01/07/2023 – 30/06/2024
APO PHARM ApS (CVR 15226072) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 1,522,064 and a net result of DKK 121,257 compared with DKK 292,960 the year before. That is an increase of 9.9% compared with the year before. Equity in the 2024 report amounted to DKK 505,483. The solvency ratio was 30.5%. The company had 5 employees in the financial year.
- Gross Profit
- DKK 1,522,064
- Profit/Loss
- DKK 121,257
- Equity
- DKK 505,483
- Total Assets
- DKK 1,658,876
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 1.5 mio. | 121 t. | 505 t. | 5 |
| 2023 | - | 1.4 mio. | 293 t. | 684 t. | 4 |
| 2022 | - | 1.3 mio. | 254 t. | 691 t. | 6 |
| 2021 | - | 1.7 mio. | 566 t. | 1 mio. | 6 |
| 2020 | - | 2.1 mio. | 678 t. | 1.1 mio. | 6 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout APO PHARM ApS
APO PHARM ApS is a Danish company of the type Anpartsselskab based in Holbæk, founded in 1991. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named VITALISTEN ApS. The management consists of Helge Larsen. The board consists of Hanne Vesti Petersen and Helge Larsen. The company is owned by VESTI LARSEN ApS. The company has 7 employees (2026). In 2025, the company reported a gross profit of DKK 1,481,073 and a net result of DKK 26,824 compared with DKK 121,257 the year before. Equity in the 2025 report amounted to DKK 332,307.